Pharmacogenomics is changing the way drugs are being developed, approved and used. The Gurwitz et al article found in the previous issue is a timely ‘call to arms’ to ensure that this important field ...

How did you first become interested in pharmacogenomics? Well, I actually started my research career in physiology/pharmacology for and then moved into classical immunology/virology in HIV/AIDS.

Now, 45 years later, after the completion of the Human Genome Project and the massive application of microarray and other molecular genetic techniques, this field of pharmacogenetics has been renamed, ...